Objective: To assess whether weekday of surgery influences long-term survival in esophageal cancer. Background: Increased 30-day mortality rates have been reported in patients undergoing elective surgery later compared with earlier in the week. Methods: This population-based cohort study included 98% of all esophageal cancer patients who underwent elective surgery in Sweden in 1987 to 2010, with follow-up until 2014. The association between weekday of surgery and 5-year all-cause and disease-specific mortality was analyzed using a multivariable Cox proportional hazards model, providing hazard ratios (HRs) with 95% confidence intervals (CIs), adjusted for age, comorbidity, tumor stage, histology, neoadjuvant therapy, and surgeon volume. Results: Among 1748 included patients, surgery conducted from Wednesday to Friday entailed 13% increased all-cause 5-year mortality compared with surgery conducted from Monday to Tuesday (HR ¼ 1.13, 95% CI, 1.01-1.26). The corresponding association was strong for early tumor stages (0-I) (HR ¼ 1.59, 95% CI, 1.17-2.16), moderate for intermediate tumor stage (II) (HR ¼ 1.28, 95% CI, 1.07-1.53), and absent in advanced tumor stages (III-IV) (HR ¼ 0.93, 95% CI, 0.79-1.09). The increase in 5-year mortality for each later weekday (discrete variable) was 7% for all tumor stages (HR ¼ 1.07, 95% CI, 1.02-1.12), 24% for early tumor stages (HR ¼ 1.24, 95% CI, 1.09-1.41), 13% for intermediate stage (HR ¼ 1.13, 95% CI, 1.05-1.22), whereas no increase was found for advanced stages (HR ¼ 0.98, 95% CI, 0.92-1.05). The disease-specific 5-year mortality was similar to the all-cause mortality. Conclusions: The increased 5-year mortality of potentially curable esophageal cancer after surgery later in the week suggests that this surgery is better carried out earlier in the week.
C uratively intended surgery for esophageal cancer (esophagectomy) is one of the most extensive standard surgical procedures carried out. [1] [2] [3] Oncologic therapy is typically used before esophagectomy. [4] [5] [6] Both short-term and long-term survival after esophagectomy is strongly dependent on the experience of the surgeon. [7] [8] [9] [10] [11] These findings have prompted centralization of esophagectomy to dedicated high-volume centers. 6, 12, 13 However, the overall 5-year postoperative survival is only approximately 30%, and strongly dependent on the tumor stage at the time of surgery, with more than 70% 5-year survival in early stages (0-I), approximately 30% in intermediate stage (II) , and less than 10% in advance stages (III-IV). 14, 15 Thus, it is important to identify other modifiable factors that can improve the postoperative prognosis. Two large cohort studies found increased 30-day mortality rates in patients who underwent elective surgery later compared with earlier in the week. 16, 17 These studies included a variety of surgical procedures and assessed shortterm mortality only, and the suggested mechanism was a ''weekend effect,'' where postoperative complications might be less well handled during weekends. We hypothesized that any prognostic effect of the weekday of surgery would be stronger for a more extensive surgical procedure such as esophagectomy, and that the long-term prognosis would be reduced due to an increased occurrence of tumor recurrence. The surgeon and the surgical team might be more focused earlier in the working week when completing demanding and time-consuming esophagectomies compared with later in the week, which in turn could influence the prognosis. There are, to the best of our knowledge, no studies that have addressed the potential influence of weekday of surgery for cancer in relation to long-term survival. Therefore, we conducted a study with the aim to test whether esophageal cancer surgery conducted during earlier weekdays is followed by a better prognosis than surgery conducted later in the week.
METHODS

Design
This nationwide Swedish population-based cohort study tested whether weekday of surgery influences the 5-year all-cause or disease-specific mortality after elective esophagectomy for esophageal cancer. The included patients represented 98% of all esophageal cancer patients in Sweden who underwent surgery during the period January 1, 1987, through December 31, 2010, and were followed up until November 13, 2014. Earlier versions of this cohort have been described elsewhere. 10, 14 All patients in Sweden with a diagnosis of esophageal cancer (identified in the Swedish Cancer Registry) who underwent esophagectomy (retrieved in the Swedish Patient Registry) were eligible. Detailed clinical data were extracted from medical records, retrieved through our Swedish network of clinicians established in the mid-1990 s as part of another nationwide study. 18 The study exposure was the day of the week on which elective esophagectomy for esophageal cancer was conducted, between Monday and Friday, as retrieved from the Swedish Patient Register. The study outcomes, 5-year all-cause mortality and 5-year disease-specific mortality, were collected from the Swedish Causes of Death Registry. The 5-year cut-off for mortality assessment was used because the vast majority of esophageal cancer patients who die within 5 years of surgery have tumor recurrence as the cause of death, and deaths occurring later than 5 years beyond surgery are rarely due to tumor recurrence, as reflected by mortality rates that are similar to the corresponding background population. 19 The linkages of individuals between registers and the identification of their medical
Data From National Registers
The Swedish Cancer Registry records all cancer diagnoses in Sweden since 1958, and was used to identify patients (with age and sex) with esophageal cancer, represented by the diagnosis codes 150.0, 150.8, or 150.9 according to the seventh version of the International Classification of Diseases. This register has 98% nationwide coverage of all esophageal cancer cases. 21, 22 The Swedish Patient Registry records all surgical procedures and diagnoses with dates and hospitals within in-hospital care in Sweden since 1987. 23 Data on esophagectomy, weekday of esophagectomy, comorbidities, and hospital admittances were collected from this register. This register has an excellent (99.6%) positive predictive value for the recording of esophageal cancer surgery. 24 The Swedish Causes of Death Registry provided dates of death until November 13, 2014, which were used to assess all-cause mortality. Information on the causes of death was available until December 31, 2013, which was used to assess disease-specific mortality, as defined by a recorded esophageal cancer recurrence in the register.
Data From Medical Records
A comprehensive data collection of medical records, including surgical charts and pathological reviews, was conducted to retrieve all relevant clinical data, including comorbidity, tumor stage, tumor location, tumor histology, neoadjuvant therapy, surgery, and annual surgeon volume of esophagectomies. The reviewers of the medical records, who were kept blinded from the study outcomes, filled in a predefined protocol to include the required clinical data in an objective manner. The assessment of the initial reviewer was validated by 2 other reviewers, which showed more than 90% exact concordance of variables subject to interpretation difficulties, for example, tumor stage. 14 Comorbidity was assessed according to the well validated Charlson comorbidity index scoring system. 25 Tumor stage, location, and histology were assessed from the pathology reports of the resected tumor specimens. Tumor stage was classified according to the TNM classification of the Union Internationale Contre le Cancer (UICC). 26 Neoadjuvant therapy was infrequently used in Sweden during the study period, which was due to the limited support of such treatment until recently. 4, 11, 27 When used, the neoadjuvant therapy of choice was a combination of chemotherapy and radiotherapy. The dominating (95%) surgical procedure throughout the study period was open transthoracic esophageal resection with intrathoracic anastomosis. The preferred esophageal substitute was a pulled-up gastric tube, anastomosed to the proximal esophagus in the thorax or neck. The surgeon volume variable was created based on a previously described algorithm, where first, the primary surgeon's chronological number of surgeries was calculated for each year over the study period. Thereafter, the surgeon with the highest chronological number of surgeries at index operation was considered responsible for the surgery. Annual surgeon volume was then calculated as the number of times the surgeon had been responsible for a surgery during the index year, whereas cumulative surgeon volume was calculated as the chronological number of operations the surgeon had been responsible for at the time of the index surgery during the inclusion period. 10 
Statistical Analysis
The weekday variable was analyzed in 3 ways. First, early weekdays of surgery (Monday-Tuesday) were compared with late weekdays (Wednesday-Friday). Second, each of the 5 weekdays was analyzed as separate categories. Third, weekday of surgery was analyzed as a discrete variable to evaluate linear trend with the following coding: Monday ¼ 1, Tuesday ¼ 2, Wednesday ¼ 3, Thursday ¼ 4, and Friday ¼ 5. Potential differences in mortality between exposure groups were analyzed using a multivariable Coxproportional hazards model, providing hazard ratios (HRs) with 95% confidence intervals (CIs) adjusted for potential confounding factors. Six predefined covariates were included in the multivariable model because of their known prognostic influence in combination with a possibility that they might influence weekday of surgery. These covariates and their categorizations were: (1) age (continuous variable), (2) comorbidity (Charlson index score 0, 1, or !2), (3) tumor stage (0-I, II, or III-IV), (4) tumor histology (adenocarcinoma or squamous cell carcinoma), (5) neoadjuvant treatment (yes or no), and (6) cumulated surgeon volume of esophagectomies (in 4 equal sized groups; <7, 7-16, 17-46, or >46). We also conducted analyses stratified for the 6 covariates using the same categorization as presented above. To manage missing data, a complete case analysis was carried out. Since the study period was long, we added an analysis restricted to the more recent calendar period (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) . Follow-up ended at date of death or end of study period, whichever occurred first. To evaluate the proportional hazards assumption, the correlation was calculated between Schoenfeld residuals for the covariates and the ranking of individual treatment failure times, and the assumption was met. The statistical software SAS 9.4 (SAS Institute, Cary, NC) was used for the data management and statistical analysis.
RESULTS
Patients
Among 1799 patients who underwent elective surgery for esophageal cancer in 1987 to 2010, representing 98% of all such procedures in Sweden, 51 (2.8%) were excluded due to missing data in any of the covariates. Characteristics of the final 1748 study participants, grouped into early (Monday or Tuesday) and later (Wednesday-Friday) weekdays of surgery are presented in Table 1 . There were no major differences in distribution of age, sex, comorbidity scores, tumor stage, or neoadjuvant therapy between the groups. Adenocarcinoma histology, higher surgeon volume, and more recent calendar period were overrepresented in the Monday to Tuesday group. The 90-day mortality was 10% in the Monday to Tuesday surgery group and 14% in the Wednesday to Friday group. The absolute 5-year all-cause mortality and the 5-year disease-specific mortality were lower when the surgery was conducted on Monday to Tuesday compared with Wednesday to Friday ( Table 1 ).
Weekday of Surgery and Risk of Mortality
The comparison of surgery later in the week (Wednesday-Friday) with earlier in the week (Monday-Tuesday) showed an increased all-cause and disease-specific 5-year mortality (adjusted HR ¼ 1.13, 95% CI, 1.01-1.26 and HR ¼ 1.15, 95% CI, 1.02-1.29, respectively) ( Table 2 and Fig. 1 ). When weekday of surgery was categorized into each of the 5 weekdays, the point HRs increased from Wednesday through Thursday to Friday. Compared with surgery on a Monday, surgery on a Friday entailed 46% and 44% increased all-cause and disease-specific mortality (HR ¼ 1.46, 95% CI, 1.15-1.85 and HR ¼ 1.44, 95% CI, 1.13-1.84), respectively. There was an average of 7% increased all-cause and disease-specific 5-year mortality for each weekday of surgery when weekday was analyzed as a discrete variable (HR ¼ 1.07, 95% CI, 1.02-1.12 for both outcomes) ( Table 2) .
In an analysis restricted to surgery conducted during a more recent calendar period (2000-2010), the risk estimates lost precision, but the point HRs were at least as high as those of the total study population (data not shown). When comparing surgery conducted on Fridays with Mondays, the HR was 1.90 (95% CI, 0.92-3.92) for surgery during the calendar period 2000 to 2010. Table 3 presents the results comparing the 5-year mortality in relation to early (Monday-Tuesday) and late (Wednesday-Friday) weekdays stratified for each of the 6 covariates included in the multivariable model. The point HRs of 5-year mortality were higher among patients of older age, with a Charlson comorbidity score of 1, with early tumor stages, squamous cell carcinoma histology, neoadjuvant therapy, and those who had surgery by higher volume surgeons. The clearest finding was the differences between tumor stages. The HRs representing all-cause mortality were greatly increased for early tumor stages (0-I) (adjusted HR ¼ 1.59, 95% CI, 1.17-2.16), and moderately increased for intermediate tumor stage (II) (HR ¼ 1.28, 95% CI, 1.07-1.53), whereas no association remained in advanced tumor stages (III-IV) ( Table 3 ). The difference in association between tumor stages was further evaluated in an analysis for each weekday of surgery and an analysis using weekday of surgery as a discrete variable. These analyses revealed doseresponse patterns between later weekday of surgery and 5-year mortality in tumor stage 0 to I, and to a more moderate level also in tumor stage II, whereas no such pattern was seen for tumor stages III to IV (Table 4 ). When comparing surgery on a Friday with surgery on a Monday, the HR of 5-year all-cause mortality was 2.69 (95% CI, 1.27-5.71) in tumor stage 0 to I, 1.78 (95% CI, 1.22-2.59) in stage II, and 1.16 (95% CI, 0.83-1.60) in stage III to IV. The HRs for weekday of surgery as a discrete variable showed an average 24% increase in risk of all-cause mortality for each weekday of surgery for tumor stage 0 to I (HR ¼ 1.24, 95% CI, 1.09-1.41), 13% increase for stage II (HR ¼ 1.13, 95% CI, 1.05-1.22), and no increase for tumor stage III to IV (HR ¼ 0.98, 95% CI, 0.92-1.05). The HRs assessing all-cause and disease-specific 5-year mortality were similar (Tables 2-4 ). In an analysis excluding the initial 90 days of surgery the associations between weekday of surgery and all-cause and disease-specific 5-year mortality remained virtually unchanged (data not shown). 
Weekday of Surgery and Risk of Mortality Stratified for Six Covariates
DISCUSSION
This study indicates that esophageal cancer surgery carried out later in the week is associated with increased all-cause and diseasespecific 5-year mortality. The risk estimates were evident for earlier tumor stages, but not for advanced tumor stages.
It is not feasible to address the relation between the 5 weekdays of surgery for esophageal cancer and risk of mortality with a randomized clinical trial, which left us with an observational design. The 4 main concerns with a cohort design, which was used in the present study, are typically selection bias, misclassification, confounding, and loss to follow-up. However, these concerns were accounted for. First, selection bias was counteracted by the population-based design with inclusion of virtually all patients in Sweden who underwent surgery for esophageal cancer. Second, the assessment of the study exposure (weekday of surgery) and outcome (mortality) was accurate. Third, although residual confounding can never be ruled out, potential confounding by all main prognostic factors was carefully adjusted for in the analyses. Fourth, there was no loss to follow-up by virtue of the nationwide complete population registers available in Sweden in combination with the personal identity numbers. Chance is another potential methodological concern, but to enable good precision we included all eligible patients in Sweden since 1987 (when the Swedish Patient Registry became nationwide) which provided robust risk estimates, for all except for some of the subanalyses. This long study period might, on the other hand, introduce confounding by changes in the treatment of esophageal cancer over time, particularly introduction of preoperative oncologic therapy and centralization of surgery. However, it is unlikely that these changes would influence choice of weekday of surgery. Moreover, all risk estimates were adjusted for both neoadjuvant therapy and surgeon volume of esophagectomies. Additionally, the analyses stratified for calendar periods showed no difference in association between weekday of surgery and mortality. Finally, all esophagectomies done in Sweden are carried out in public hospitals where the individual surgeon cannot choose the day of scheduled surgery. Therefore, factors like the age or experience of the surgeon would not influence the choice of operation day in this study. This is in contrast to many other countries where the individual surgeon together with his patient can decide what day of the week to operate on.
To the best of our knowledge, this is the first study addressing the role of weekday of cancer surgery in relation to long-term survival. Previous research has identified earlier weekday of surgery as beneficial in the short term (30 days) after elective surgery for various disorders. 16, 17 Some research has also revealed that surgical procedures conducted during weekends carry higher 30-day mortality compared with surgery carried out during weekdays. 28 However, long-term effects were not addressed and the hypothesis of previous studies has been that the health care services are of lower quality during weekends. The hypothesis of the present study was instead that the surgical precision might to some extent deteriorate later in the week due to the workload of the surgeons and the surgical team. The fact that surgery for esophageal cancer is among the most challenging surgical procedures carried out could contribute to the findings. The results of the present study indicate that the outcomes after esophageal cancer surgery might be influenced by the alertness of the surgeon. Esophageal cancer surgery typically requires several hours (the average operation duration for esophagectomy in Sweden is 6 1 /2 hours) of focused work by the surgeon. It might be argued that the surgeon is likely to be well-rested earlier in the working week compared with later in the week and therefore will find it easier to focus on exhausting and demanding surgery. This in turn might result in more precise surgery, followed by a lower risk of later tumor recurrence. This hypothesis gains support from the findings of stronger associations in high-volume surgeons and in earlier tumor stages. High-volume surgeons might conduct several esophagectomies each week, which is exhaustive. This also indicates that the ongoing centralization of services might enhance the weekday effects seen in the present study. In earlier tumor stages surgery plays a more crucial role for the chance of long-term survival, whereas the lack of association in advanced tumor stages might be due to the low chance of cure (<10% 5-year survival). 14, 15 The findings of this study need confirmation in other studies. If proven true, these results argue in favor of a change of the scheduling of esophageal cancer surgery to the first part of the week, whereas less time-consuming and tiring surgery might be scheduled for later in the week. Although this study focused on surgery for esophageal cancer, it is fully possible that the results might be generalizable to other challenging surgical cancer procedures, for example, surgery for cancer of pancreas, bile ducts, and liver.
In conclusion, this large and population-based cohort study with adjustment for prognostic factors and complete follow-up indicates that esophageal cancer surgery for more readily surgically curable tumor stages (0-II) is followed by a better all-cause and disease-specific 5-year survival if conducted earlier during the week compared with later. Thus, changes in the scheduling of esophageal cancer surgery might improve the prognosis in patients operated on for esophageal cancer. 
